ArticleBMC nephrology2026
Development of a high-altitude renal disease diagnostic model based on machine learning and multiple biomarker detection: a retrospective study of 19,068 patients.
Article in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
BACKGROUND AND
aimsEarly detection of chronic kidney disease (CKD) in high-altitude regions remains difficult due to physiological adaptations that may affect conventional biomarkers. This study aimed to develop machine learning-based diagnostic models tailored to high-altitude populations. MATERIALS AND
methodsThis retrospective cohort study included 19,068 individuals living in high-altitude regions (≈ 2300 m) who attended Qinghai Provincial People's Hospital between 2019 and 2022. Regression models were constructed to estimate glomerular filtration rate (GFR) as a continuous outcome, while classification models were developed to diagnose CKD based on KDIGO criteria. Artificial neural networks (ANN), LASSO regression, ridge regression, and linear regression were implemented for GFR prediction. A subgroup of 289 patients undergoing 99mTc-DTPA renal dynamic imaging served as a physiological reference for external model assessment. Classification algorithms included logistic regression, k-nearest neighbors (KNN), support vector machines (SVM), decision trees, naive Bayes, random forest (RF), and ANN. The dataset was split into training (80%) and testing (20%) cohorts using stratified sampling. Five-fold cross-validation was applied for hyperparameter tuning. Model performance was evaluated using AUC, correlation coefficients, precision, recall, and calibration metrics.
resultsIn regression models predicting GFR, ANN achieved the highest performance (AUC = 0.87), outperforming the CKD-EPI formula. In the 99mTc-DTPA subgroup, ridge regression showed the best discrimination (AUC = 0.88). In classification models, RF demonstrated superior performance (AUC = 0.92). All ML models outperformed traditional GFR equations.
conclusionMachine learning models significantly improve diagnostic accuracy of CKD in high-altitude populations. ANN and RF models demonstrated promising predictive capability, supporting their potential clinical application in high-altitude regions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.